Drug prices and trends for CHILD PAIN-FEVER

Subscribe to access the full database, or Try for Free
Drug Name	NDC	Price/Unit ($)	Unit	Date
CHILD PAIN-FEVER 160 MG/5 ML	46122-0322-26	0.02007	ML	2025-03-19
CHILD PAIN-FEVER 160 MG/5 ML	70000-0028-01	0.02007	ML	2025-03-19
CHILD PAIN-FEVER 160 MG/5 ML	46122-0211-26	0.02007	ML	2025-03-19
CHILD PAIN-FEVER 160 MG/5 ML	83474-0001-04	0.02007	ML	2025-03-19
CHILD PAIN-FEVER 160 MG/5 ML	46122-0209-26	0.02007	ML	2025-03-19
CHILD PAIN-FEVER 160 MG/5 ML	83720-0500-16	0.01226	ML	2025-03-19
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Market Overview

The market for antipyretic drugs for children has been experiencing robust growth, driven by several key factors. As of 2023, the global market size for these drugs was valued at $3.02 billion and is projected to reach $3.21 billion in 2024, with a compound annual growth rate (CAGR) of 6.4%[1][3].

Market Drivers

Several drivers are contributing to the growth of this market:

Increasing Awareness of Pediatric Health: Heightened awareness of pediatric health has led to a higher demand for antipyretic medications. Parents and caregivers are more proactive in seeking medical treatments for common childhood fevers[1][3].
Growing Incidence of Fever-Related Illnesses: The increasing incidence of fever-related illnesses in children globally is a significant driver. Viral infections, such as COVID-19, RSV, and the flu, have been particularly impactful[1][3][5].
Rising Healthcare Expenditures: Families are spending more on healthcare to treat common childhood fevers, which includes the purchase of antipyretic drugs[1][3].
Improved Access to Over-the-Counter Drugs: Better access to over-the-counter antipyretic drugs in emerging markets has also boosted demand[1][3].

Market Segmentation

The antipyretic drugs for children market is segmented in several ways:

By Drug Class

Acetaminophen: One of the most commonly used antipyretics, often recommended for children due to its safety profile.
Ibuprofen: Another widely used NSAID for fever reduction and pain relief in children.
Other Drug Classes: This includes aspirin, though its use in children is less common due to safety concerns[1][2][4].

By Dosage Form

Tablets: Solid dosage forms that are often used for older children.
Syrups: Liquid forms that are more suitable for younger children.
Suppositories: Used for children who cannot take oral medications.
Other Dosage Forms: Includes various formulations to cater to different age groups and preferences[1][3].

By Age Group

Newborns: Specialized formulations for the youngest age group.
Infants: Formulations designed for infants.
Toddlers: Formulations suitable for toddlers.
Children: General formulations for older children[1].

Geographic Market

The market is geographically segmented into:

North America: Expected to experience significant growth due to the well-developed healthcare industry and higher antiviral drug costs[2].
Europe: Trails North America but is growing due to increasing healthcare awareness and treatment needs in developing regions[2].
Asia Pacific: Growing rapidly due to expanding pharmaceutical companies and increasing healthcare access[1][3].
Rest of the World: Includes other regions with varying levels of market growth[2].

Forecast and Growth Projections

The market is expected to continue its strong growth trajectory:

By 2028, the market size is projected to reach $4.16 billion at a CAGR of 6.7%[1][3].
By 2031, the market is expected to reach $5.2 billion at a CAGR of 4.5%[2].

Key Trends

Several trends are shaping the future of the antipyretic drugs for children market:

Technological Innovations: Advances in drug formulations and delivery mechanisms are enhancing the efficacy and safety of antipyretics[1][3].
Natural and Herbal-Based Drugs: There is a growing interest in natural and herbal-based antipyretic drugs for children[1][3].
Personalized Treatments: An increasing focus on personalized treatments for managing fevers in children[1][3].
Telemedicine Adoption: Growing use of telemedicine platforms for accessing pediatric consultations related to fever management[1][3].
Combination Antipyretic Drugs: Development of combination drugs that target multiple symptoms in children[1][3].

Challenges and Restraints

Despite the growth, the market faces some challenges:

Price Gouging: During times of high demand, such as the "tripledemic" of COVID-19, RSV, and the flu, there have been reports of price gouging for children’s painkillers and fever reducers[5].
Consumer Confusion: The availability of multiple products with similar ingredients can lead to consumer confusion, particularly in the nonprescription segment[4].

Consumer Alert and Regulatory Oversight

Regulatory bodies are vigilant about price gouging and consumer protection. For instance, the New York Attorney General has cautioned against price gouging of children’s painkillers and fever reducers, encouraging consumers to report any excessive price increases[5].

Key Takeaways

The antipyretic drugs for children market is growing strongly due to increased awareness of pediatric health, rising healthcare expenditures, and better access to over-the-counter drugs.
The market is segmented by drug class, dosage form, and age group.
Technological innovations, natural and herbal-based drugs, personalized treatments, telemedicine adoption, and combination antipyretic drugs are key trends.
The market faces challenges such as price gouging and consumer confusion.
Regulatory bodies are actively monitoring the market to protect consumers.

FAQs

Q: What are the primary drivers of the antipyretic drugs for children market? A: The primary drivers include increasing awareness of pediatric health, growing incidence of fever-related illnesses, rising healthcare expenditures, and improved access to over-the-counter drugs.

Q: Which regions are expected to see significant growth in the antipyretic drugs for children market? A: North America, Europe, and the Asia Pacific are expected to see significant growth due to various factors such as well-developed healthcare industries and increasing healthcare awareness.

Q: What are some of the key trends in the antipyretic drugs for children market? A: Key trends include technological innovations in drug formulations, a shift towards natural and herbal-based drugs, personalized treatments, telemedicine adoption, and the development of combination antipyretic drugs.

Q: How is the market segmented? A: The market is segmented by drug class (acetaminophen, ibuprofen, other drug classes), dosage form (tablets, syrups, suppositories, other), and age group (newborns, infants, toddlers, children).

Q: What challenges does the market face? A: The market faces challenges such as price gouging during times of high demand and consumer confusion due to the availability of multiple similar products.

Sources

The Business Research Company - Antipyretic Drugs For Children Global Market Report 2024
Verified Market Research - Antipyretic Drugs for Children Market Size, Share & Forecast
GII Research - Antipyretic Drugs For Children Global Market Report 2024
FDA - Nonprescription Analgesic/Antipyretic Drug Development in Children
New York Attorney General - Consumer Alert: Attorney General James Cautions Against Price Gouging of Children’s Medication

Drug Price Trends for CHILD PAIN-FEVER

Average Pharmacy Cost for CHILD PAIN-FEVER

Market Analysis and Price Projections for Antipyretic Drugs for Children